Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 18, 2019

Magnetic hearing devices may interfere with shunt systems, says FDA

The US Food and Drug Administration (FDA) has issued a statement warning healthcare providers about potential complications in patients fitted with both programmable cerebrospinal fluid (CSF) shunt systems and certain magnetic hearing devices.

By Chloe Kent

The US Food and Drug Administration (FDA) has issued a statement warning healthcare providers about potential complications in patients fitted with both programmable cerebrospinal fluid (CSF) shunt systems and certain magnetic hearing devices.

In an open letter to healthcare providers issued on 16 July, the agency warned that magnetic interactions between the devices may occur when they are implanted within close proximity to each other, leading to unintended changes to the CSF shunt valve settings. This could occur in patients fitted with cochlear implants, bone conduction hearing devices or middle ear hearing devices, the agency said.

CSF shunt systems are commonly used to treat hydrocephalus, swelling of the brain due to excess build-up of cerebrospinal fluid. The shunt is supposed to redirect the excess fluid to the abdomen or the heart where it can be absorbed, but if magnetic interactions inadvertently change the CSF shunt settings, then over- or under-drainage of CSF may occur.

If this happens, patients may experience symptoms such as altered mental state, headache, lethargy, vomiting, visual changes and difficulty walking. Untreated, this may progress to loss of consciousness, seizures, haemorrhage or even death.

The FDA has recommended that caregivers educate patients about this potential risk to ensure they know when to have their CDF shunt checked, and what dangerous symptoms to look out for.

The agency has also advised clinicians to check the programmable CSF shunt valve setting after placement or adjustment of other devices that contain magnets to ensure that the setting has not changed.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

It recommends that healthcare providers attempt to place programmable CSF shunt valves on the opposite site of the head to a patient’s magnetic implanted hearing device. For patients with bilateral magnetic hearing implants and a CSF shunt, physicians are advised to position the shunt and the hearing implants as far away from each other as possible.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU